| Literature DB >> 34738570 |
Alessandro Carrara1, Dalia Amabile2, Riccardo Pertile3, Federico Reich4, Francesca Laura Nava5, Paolo Moscatelli6, Luigi Pellecchia7, Michele Motter8, Orazio Zappalà9, Gianmarco Ghezzi10, Pierpaolo Benetollo11, Giuseppe Tirone12.
Abstract
Background and aim This study analyses the impact of the first two pandemic waves on surgical urgencies/emergencies and their consequences on an entire provincial hospital network's surgical activities. Methods Clinical and epidemiological data of urgent/emergent surgical admissions and interventions in the Autonomous Province of Trento's hospital network were collected from the internal common electronic database. The investigation periods were March-May 2019 (reference period), March-May 2020 (phase-I), June - August 2020 (phase-II), and October - December 2020 (phase-III). The same data were divided and grouped for the six most represented diagnoses.Entities:
Mesh:
Year: 2021 PMID: 34738570 PMCID: PMC8689315 DOI: 10.23750/abm.v92i5.11620
Source DB: PubMed Journal: Acta Biomed ISSN: 0392-4203
Figure 1.Hospital network of Trentino: 2 hub and 5 spoke hospitals for a total of 131 surgical beds
Severity Index for the three pandemic phases compared to 2019 (03-05)
|
|
|
|
|
|
| |
| 0 (<65), 1(65-80), 2(>80) | 0 (<4,5), 1(4,5-4,9), 2(5-5,4), 3(5,5-5,9), 4(>6) | 0 (<0,8), 1(0,8-1,05), 2(1,06-2,0), 3(>2,0) | 0 (<0,5), 2(0,5-1,5), 4(>1,5) | 2 (<80), 1(80-85), 0(>85) | 0-15 | |
|
| 0 | 0 | 1 | 2 | 0 |
|
|
| 1 | 4 | 2 | 4 | 1 |
|
|
| 0 | 1 | 1 | 2 | 0 |
|
|
| 1 | 3 | 2 | 4 | 0 |
|
Figure 2.Number pf SUEs in the Hospital Network of the APSS: 2019 (03-05) vs phase I vs phase II vs phase III.
Figure 3.Weekly number hospital admissions for SUEs in the three pandemic phases compared to 2019 (03-05)
Wilcoxon-Mann-Whitney test comparing quantitative variables of SUEs in 2019 and in the three pandemic phases.
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
| 71.2 (10.4) | 64.9-77.5 | nf |
| 0,4246 |
| |
| 38.8 (13.8) | 30.4-47.1 |
| nf |
| 0,0946 | |
| 67.7 (12.2) | 60.3-75.1 | 0,4246 |
| nf |
| |
| 48.5 (10.1) | 42.5-54.6 |
| 0,0946 |
| nf | |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
| 4.79 (4.39) | 4.51-5.07 | nf |
|
| 0,7229 | |
| 6.04 (6.31) | 5.49-6.59 |
| nf | 0,4219 |
| |
| 5.47 (5.19) | 5.13-5.82 |
| 0,4219 | nf | 0,0671 | |
| 5.53 (8.08) | 4.90-6.16 | 0,7229 |
| 0,0671 | nf | |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
| 58.3 (21.8) | 56.9-59.7 | nf |
| 0,0777 |
| |
| 62.6 (20.7) | 60.8-64.4 |
| nf |
| 0,1395 | |
| 60.1 (21.2) | 58.7-61.5 | 0,0777 |
| nf | 0,5887 | |
| 60.4 (22.0) | 58.7-62.2 |
| 0,1395 | 0,5887 | nf |
Figure 4.Variations in admissions for SUEs (%) in the three pandemic phases compared to 2019 (03-05)
Wilcoxon-Mann-Whitney test comparing mean weekly number of admissions according to different diagnosis in 2019 and in the three pandemic phases.
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
| 7.62 (2.75) | 5.95 - 9.28 | nf |
| 0,1344 |
|
|
| 3.46 (2.79) | 1.78 - 5.15 |
| nf |
| 0,5489 |
|
| 5.85 (2.73) | 4.19 - 7.5 | 0,1344 |
| nf | 0,0978 |
|
| 4.15 (3.11) | 2.28 - 6.03 |
| 0,5489 | 0,0978 | nf |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
| 10.77 (3.17) | 8.86 - 12.68 | nf |
| 0,3129 | 0,3275 |
|
| 7.15 (3.21) | 5.21 - 9.09 |
| nf |
| 0,0711 |
|
| 12.46 (3.76) | 10.19 - 14.73 | 0,3129 |
| nf |
|
|
| 9.62 (3.12) | 7.73 - 11.5 | 0,3275 | 0,0711 |
| nf |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
| 8.15 (2.23) | 6.81 - 9.50 | nf |
|
| 0,7562 |
|
| 4.85 (3.11) | 2.97 - 6.72 |
| nf |
|
|
|
| 9.77 (2.01) | 8.56 - 10.98 |
|
| nf | 0,1402 |
|
| 8.00 (3.03) | 6.17 - 9.83 | 0,7562 |
| 0,1402 | nf |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
| 7.23 (2.09) | 5.97 - 8.49 | nf | 0,060 | 0,3793 |
|
|
| 5.46 (2.07) | 4.21 - 6.71 | 0,060 | nf |
| 0,979 |
|
| 8.46 (3.1) | 6.59 - 10.33 | 0,3793 |
| nf |
|
|
| 5.38 (2.02) | 4.16 - 6.61 |
| 0,979 |
| nf |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
| 17.69 (6.63) | 13.69 - 21.7 | nf |
| 0,6436 |
|
|
| 6.00 (4.02) | 3.57 - 8.43 |
| nf |
| 0,0754 |
|
| 18.46 (6.09) | 14.78 - 22.14 | 0,6436 |
| nf |
|
|
| 9.23 (4.64) | 6.43 - 12.03 |
| 0,0754 |
| nf |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
|
| 1,14-1.94 | nf | 0,759 | 0,7181 | 0,865 |
|
|
| 1,07-2.32 | 0,759 | nf | 0,5705 | 0,6398 |
|
|
| 0,83-2.1 | 0,7181 | 0,5705 | nf | 0,8912 |
|
|
| 0,99-1-93 | 0,865 | 0,6398 | 0,8912 | nf |
|
|
|
| p-value vs 2019 | p-value vs phase I | p-value vs phase II | p-value vs phase III |
|
| 1.62 (1.12) | 0.94-2.29 | nf | 0,3613 | 0,6269 | 0,3404 |
|
| 1.15 (1.07) | 0.51-1.80 | 0,3613 | nf | 0,1439 | 0,872 |
|
| 2,00 (1.29) | 1.22-2.78 | 0,6269 | 0,1439 | nf | 0,1223 |
|
| 1.31 (1.11) | 0.64-1.98 | 0,3404 | 0,872 | 0,1223 | nf |
Chi square test comparing surgical rate in 2019 and in the three pandemic phases
|
|
|
|
| p-value vs 2019 | p-value vs Phase I | p-value vs Phase II | p-value vs Phase III | |
|
| 245 | 25,6% | 712 | 74,4% | nf |
|
|
|
|
| 180 | 35,2% | 331 | 64,8% |
| nf | 0,199025 | 0,738829 |
|
| 283 | 31,9% | 605 | 68,1% |
| 0,199025 | nf | 0,323637 |
|
| 217 | 34,3% | 416 | 65,7% |
| 0,738829 | 0,323637 | nf |
Figure 5.Variations in surgical rate for SUEs (%) in the three pandemic phases compared to 2019 (03-05)
Chi square test comparing gender in 2019 and in the three pandemic phases.
|
|
|
|
| p-value vs 2 019 | p-value vs Phase I | p-value vs Phase II | p-value vs Phase III | |
|
| 528 | 55,2% | 429 | 44,8% | nf | 0,31122 | 0,304593 |
|
|
| 296 | 57,9% | 215 | 42,1% | 0,311222 | nf | 0,889659 | 0,137821 |
|
| 511 | 57,5% | 377 | 42,5% | 0,304593 | 0,88966 | nf | 0,065783 |
|
| 394 | 62,2% | 239 | 37,8% |
| 0,13782 | 0,065783 | nf |
Figure 6.Prevalence of alcoholics binge abuse in PAT. Passi, 2011-2020 (n=4.543). Classified as binge consumers are men who consume 5 or more alcoholic units on one occasion, women who consume 4 or more alcohol units on one occasion. [*Data refer to March-July 2020 (n=128)].
Figure 7.Renounce to medical assistance in the over 60 yrs population during the first wave of the COVID-19 pandemic. PASSI d’Argento 2020.